CA15-3

Test information: Guidelines suggest that CA15-3 should be used for the monitoring of treatment in breast cancer. It is not recommended for screening, diagnosis or staging of breast cancer, due to the test low sensitivity in early disease and can be raised in other conditions. .

Specimen Type(s)

• Blood;

Other Acceptable Specimen Type(s)

N/A

Specimen Container - Adult

• Gold Top SST BD;

Specimen Container - Paediatric

• Clear - Plain;

Analytes

• N/A;

Part of a test profile?

No

Volume (min) of sample to be sent to laboratory

1ml

Patient Preparation, Sample Handling and Transport

N/A

Maximum add on time

3 days

Units and Reference Ranges / Interpretation

Please see the report.

UKAS number

8494

UKAS accredited test?

Yes

Comments

N/A

If you have any queries about a test or results interpretation please contact us.